Wegovy is a weight loss drug that was approved by the FDA in June 2021. It contains the active ingredient semaglutide, which is also used in another drug called Ozempic [2]. According to Drug Patent Watch, Wegovy is expected to be more expensive than Ozempic, with a list price of $1,350 for a four-week supply [1]. However, it is important to note that the actual cost may vary depending on insurance coverage and other factors.

Despite its higher cost, Wegovy may potentially save money in the long run for individuals struggling with obesity. The drug has been shown to be effective in clinical trials, with participants losing an average of 15% of their body weight [2]. This weight loss can lead to improvements in overall health and a reduced risk of obesity-related conditions such as diabetes and heart disease. In turn, this can lead to lower healthcare costs associated with treating these conditions.

Wegovy also offers a savings program for eligible patients, which can help reduce the cost of the drug. This program includes a savings card that can be used at participating pharmacies to save up to $200 per prescription [3].

In conclusion, while Wegovy may be more expensive than other weight loss drugs, its effectiveness in promoting weight loss and potential long-term cost savings through improved health outcomes make it a viable option for individuals struggling with obesity. However, it is important to consider individual insurance coverage and other factors when evaluating the cost of the drug.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.npr.org/sections/health-shots/2023/01/30/1152039799/ozempic-wegovy-weight-loss-drugs
[3] https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html